Clinical Outcomes After Unilateral Adrenalectomy for Primary Aldosteronism

Abstract

; for the International CONNsortium study group IMPORTANCE In addition to biochemical cure, clinical benefits after surgery for primary aldosteronism depend on the magnitude of decrease in blood pressure (BP) and use of antihypertensive medications with a subsequent decreased risk of cardiovascular and/or cerebrovascular morbidity and drug-induced adverse effects. OBJECTIVE To evaluate the change in BP and use of antihypertensive medications within an international cohort of patients who recently underwent surgery for primary aldosteronism. DESIGN, SETTING, AND PARTICIPANTS A cohort study was conducted across 16 referral medical centers in Europe, the United States, Canada, and Australia. Patients who underwent unilateral adrenalectomy for primary aldosteronism between January 2010 and December 2016 were included. Data analysis was performed from August 2017 to June 2018. Unilateral disease was confirmed using computed tomography, magnetic resonance imaging, and/or adrenal venous sampling. Patients with missing or incomplete preoperative or follow-up data regarding BP or corresponding number of antihypertensive medications were excluded. MAIN OUTCOMES AND MEASURES Clinical success was defined based on postoperative BP and number of antihypertensive medications. Cure was defined as normotension without antihypertensive medications, and clear improvement as normotension with lower or equal use of antihypertensive medications. In patients with preoperative normotensivity, improvement was defined as postoperative normotension with lower antihypertensive use. All other patients were stratified as no clear success because the benefits of surgery were less obvious, mainly owing to postoperative, persistent hypertension. Clinical outcomes were assessed at follow-up closest to 6 months after surgery. RESULTS On the basis of inclusion and exclusion criteria, a total of 435 patients (84.6%) from a cohort of 514 patients who underwent unilateral adrenalectomy were eligible. Of these patients, 186 (42.3%) were women; mean (SD) age at the time of surgery was 50.7 (11.4) years. Cure was achieved in 118 patients (27.1%), clear improvement in 135 (31.0%), and no clear success in 182 (41.8%). In the subgroup classified as no clear success, 166 patients (91.2%) had postoperative hypertension. However, within this subgroup, the mean (SD) systolic and diastolic BP decreased significantly by 9 (22) mm Hg (P < .001) and 3 (15) mm Hg (P = .04), respectively. Also, the number of antihypertensive medications used decreased from 3 (range, 0-7) to 2 (range, 0-6) (P < .001). Moreover, in 75 of 182 patients (41.2%) within this subgroup, the decrease in systolic BP was 10 mm Hg or greater. CONCLUSIONS AND RELEVANCE In this study, for most patients, adrenalectomy was associated with a postoperative normotensive state and reduction of antihypertensive medications. Furthermore, a significant proportion of patients with postoperative, persistent hypertension may benefit from adrenalectomy given the observed clinically relevant and significant redu...

Adrenal artery ablation for primary aldosteronism without apparent aldosteronoma: An efficacy and safety, proof‐of‐principle trial

“…Patients treated with adrenal ablation had more marked decrease in blood pressure and were able to reduce DDD of their antihypertensive drugs. The complete clinical success rate (25%) after adrenal ablation in this study was equivalent to that achieved with unilateral adrenalectomy in a recent study (27%) 28 . However, the biochemical success rate was lower with adrenal ablation than with adrenalectomy.…”

“…The complete clinical success rates through adrenalectomy in PA patients varied widely (27%‐52%) in previous reports 27,28 . Recently, the PASO study established a set of standardized criteria for reporting clinical and biochemical outcomes of adrenalectomy for unilateral PA 22 .…”

Predicting factors related with uncured hypertension after retroperitoneal laparoscopic adrenalectomy for unilateral primary aldosteronism

“…The results on clinical cures vary extensively across studies (22–84%). [16,19,20,23] Uncured hypertension is most likely due to coexistent essential hypertension and subsequent irreversible vascular changes, induced by both hypertension itself and direct exposure to aldostrerone despite a metabolic cure. [24,25] It has also been observed that the prevalence of hypertension in patients with uncured hypertension after adrenalectomy was almost the same as the prevalence of essential hypertension in a random population of the same age.…”

Update: Selective adrenal venous sampling (AVS) – Indication, technique, and significance

“…Die operative Therapie im Falle einer gesicherten Lateralisierung ist nach wie vor die Therapie der Wahl bei PHA [51]. Interventionellradiologische Therapieoptionen wie die Radiofrequenzablation können möglicherweise zukünftig, u. a. bei multimorbiden oder älteren Patienten, einen alternativen Therapieansatz darstellen [52].…”